Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
Go back to Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.80 +0.16 (6.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.64 | 52 Week High | $1.63 | |||
| Open | $2.67 | 52 Week Low | $0.71 | |||
| Day High | $2.85 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $0.00 | |||
| Volume | 19,508 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.80 +0.16 (6.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.64 | 52 Week High | $1.63 | |||
| Open | $2.67 | 52 Week Low | $0.71 | |||
| Day High | $2.85 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $0.00 | |||
| Volume | 19,508 | |||||
